Regulation of immune responses by E3 ubiquitin ligase Cbl-b

Rong Tang, Wallace Y. Langdon, Jian Zhang

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Casitas B lymphoma-b (Cbl-b), a RING finger E3 ubiquitin ligase, has been identified as a critical regulator of adaptive immune responses. Cbl-b is essential for establishing the threshold for T cell activation and regulating peripheral T cell tolerance through various mechanisms. Intriguingly, recent studies indicate that Cbl-b also modulates innate immune responses, and plays a key role in host defense to pathogens and anti-tumor immunity. These studies suggest that targeting Cbl-b may represent a potential therapeutic strategy for the management of human immune-related disorders such as autoimmune diseases, infections, tumors, and allergic airway inflammation. In this review, we summarize the latest developments regarding the roles of Cbl-b in innate and adaptive immunity, and immune-mediated diseases.

Original languageEnglish
JournalCellular Immunology
DOIs
Publication statusE-pub ahead of print - 7 Nov 2018

Fingerprint

Ubiquitin-Protein Ligases
Lymphoma
Immune System Diseases
Adaptive Immunity
Innate Immunity
T-Lymphocytes
Autoimmune Diseases
Immunity
Neoplasms
Inflammation
Infection

Cite this

@article{7bfc7cf427904669bd3ef6c076ccd35f,
title = "Regulation of immune responses by E3 ubiquitin ligase Cbl-b",
abstract = "Casitas B lymphoma-b (Cbl-b), a RING finger E3 ubiquitin ligase, has been identified as a critical regulator of adaptive immune responses. Cbl-b is essential for establishing the threshold for T cell activation and regulating peripheral T cell tolerance through various mechanisms. Intriguingly, recent studies indicate that Cbl-b also modulates innate immune responses, and plays a key role in host defense to pathogens and anti-tumor immunity. These studies suggest that targeting Cbl-b may represent a potential therapeutic strategy for the management of human immune-related disorders such as autoimmune diseases, infections, tumors, and allergic airway inflammation. In this review, we summarize the latest developments regarding the roles of Cbl-b in innate and adaptive immunity, and immune-mediated diseases.",
keywords = "Cbl-b, Immune-related disorders, Innate and adaptive immune responses, T cell tolerance, Ubiquitination",
author = "Rong Tang and Langdon, {Wallace Y.} and Jian Zhang",
year = "2018",
month = "11",
day = "7",
doi = "10.1016/j.cellimm.2018.11.002",
language = "English",
journal = "Cellular Immunology",
issn = "0008-8749",
publisher = "Academic Press",

}

Regulation of immune responses by E3 ubiquitin ligase Cbl-b. / Tang, Rong; Langdon, Wallace Y.; Zhang, Jian.

In: Cellular Immunology, 07.11.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Regulation of immune responses by E3 ubiquitin ligase Cbl-b

AU - Tang, Rong

AU - Langdon, Wallace Y.

AU - Zhang, Jian

PY - 2018/11/7

Y1 - 2018/11/7

N2 - Casitas B lymphoma-b (Cbl-b), a RING finger E3 ubiquitin ligase, has been identified as a critical regulator of adaptive immune responses. Cbl-b is essential for establishing the threshold for T cell activation and regulating peripheral T cell tolerance through various mechanisms. Intriguingly, recent studies indicate that Cbl-b also modulates innate immune responses, and plays a key role in host defense to pathogens and anti-tumor immunity. These studies suggest that targeting Cbl-b may represent a potential therapeutic strategy for the management of human immune-related disorders such as autoimmune diseases, infections, tumors, and allergic airway inflammation. In this review, we summarize the latest developments regarding the roles of Cbl-b in innate and adaptive immunity, and immune-mediated diseases.

AB - Casitas B lymphoma-b (Cbl-b), a RING finger E3 ubiquitin ligase, has been identified as a critical regulator of adaptive immune responses. Cbl-b is essential for establishing the threshold for T cell activation and regulating peripheral T cell tolerance through various mechanisms. Intriguingly, recent studies indicate that Cbl-b also modulates innate immune responses, and plays a key role in host defense to pathogens and anti-tumor immunity. These studies suggest that targeting Cbl-b may represent a potential therapeutic strategy for the management of human immune-related disorders such as autoimmune diseases, infections, tumors, and allergic airway inflammation. In this review, we summarize the latest developments regarding the roles of Cbl-b in innate and adaptive immunity, and immune-mediated diseases.

KW - Cbl-b

KW - Immune-related disorders

KW - Innate and adaptive immune responses

KW - T cell tolerance

KW - Ubiquitination

UR - http://www.scopus.com/inward/record.url?scp=85056260874&partnerID=8YFLogxK

U2 - 10.1016/j.cellimm.2018.11.002

DO - 10.1016/j.cellimm.2018.11.002

M3 - Article

JO - Cellular Immunology

JF - Cellular Immunology

SN - 0008-8749

ER -